Magenta Therapeutics Inc
Change company Symbol lookup
Select an option...
MGTA Magenta Therapeutics Inc
PT Pintec Technology Holdings Ltd
CLSH CLS Holdings USA Inc
UN Unilever NV
AWK American Water Works Company Inc
AEG Aegon NV
SBUX Starbucks Corp
PFE Pfizer Inc
CRON Cronos Group Inc
CVSI CV Sciences Inc

Health Care : Biotechnology | Company profile

Magenta Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is developing therapeutics to transform hematopoietic stem cell transplants for patients with immune and blood-based diseases. It maintains a platform with integrated and modular approach, which aims to reboot the blood and immune systems. The Company’s products include MGTA-145, MGTA-456, E478, and G100. The Company also developing a pipeline of small molecules; biologics, including antibody drug conjugates; and a cell therapy, which transplant options for many more patients with autoimmune diseases, blood cancers and genetic diseases. The Company’s C100 program targets HSCs, immune cells, and disease-causing cells, the C200 program targets HSCs and disease-causing cells and the C300 program targets only immune cells. This is achieved by tuning the antibodies to specific cellular markers or receptors that are expressed on the particular cell types.

Day's Change
-0.21 (-1.18%)
B/A Size
Day's High
Day's Low

Today's volume of 180,735 shares is on pace to be much lighter than MGTA's 10-day average volume of 396,664 shares.


UPDATE: Whole Foods launches digital catalog organized by dietary preference

12:21 pm ET January 3, 2019 (MarketWatch)
Print Inc.'s (AMZN) Whole Foods Market has launched an online catalog ( that lets shoppers search by dietary preference, and provides nutritional information and ingredients, the grocer said on Thursday. Whole Foods' own data shows that many customers shop according to dietary choices. And Moody's analysis, published in October, shows that while online penetration for food was less than 2%, there's growth potential. "The e-commerce battle for supermarkets has assumed greater intensity since Amazon swooped up Whole Foods in 2017 for $13.7 billion," Moody's wrote. "Food has become a big battleground for retailers like Walmart, Costco, Target and more recently Amazon, which are looking to leverage food offerings to gain greater share across a range of other goods - yet another factor pressuring margins in this industry." Whole Foods customers can filter through products based on diets like vegan, low sodium or paleo-friendly. Amazon shares are up 26% for the past year while the S&P 500 index has slipped 8.7% for the period.

-Tonya Garcia; 415-439-6400;

(END) Dow Jones Newswires

January 03, 2019 12:21 ET (17:21 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.